Advertisement

Skin Manifestation in Dermatomyositis

  • László CzirjákEmail author
  • Endre Kálmán
Chapter

Abstract

Dermatomyositis (DM) is a systemic autoimmune disorder with skin, muscle involvement, and other manifestations including polyarthritis, interstitial lung fibrosis, and, in 20–25 % of the cases, a coexistent malignancy. Muscle symptoms include proximal limb weakness, myalgia, and tenderness. In classic dermato-/polymyositis, cutaneous manifestation occurs in 30–40 % of the adult and 95 % of the juvenile cases. 4–8.2 % of the patients with DM show exclusively skin symptoms and never develop muscle involvement. Photosensitivity is an important clinical feature of DM.

Skin symptoms include a violaceous erythema, Gottron’s papules appearing over the metacarpophalangeal, interphalangeal, elbow, and knee joints. DM-related skin symptoms also include periorbital (heliotrope) edematous rash overlying of the eyelids and periorbital tissue. A diffuse flat purple-red skin violaceous erythema may also be present on the dorsal surface of the arms and fingers; over the deltoids, posterior shoulders, and neck (“shawl sign”); V area of anterior neck and upper chest; and central aspect of the face. Periungual telangiectasia also belongs to the typical DM-related skin signs. Further secondary changes of DM include scale, follicular hyperkeratosis, pigmentary changes, subepidermal bullous change, and ulceration. Poikiloderma atrophicans vasculare (poikilodermatomyositis) that is a circumscribed violaceous erythema with associated telangiectasia, hypopigmentation, hyperpigmentation, and superficial atrophy may be present in certain parts of the body including the V area of anterior neck and upper chest, back, flanks, and buttocks. Occasionally, calcinosis cutis may also appear.

The term amyopathic DM (ADM) (synonymous with “DM sine myositis”) and furthermore a closely related form of DM, “hypomyopathic DM,” (HDM) are characterized by the appearance of typical skin disease for at least 6 months without having any muscle weakness.

Cancer-associated DM is probably much more prevalent in adults than it has previously been suspected. Almost all children with DM also develop cutaneous manifestations usually before the diagnosis of myositis.

Keywords

Inclusion Body Myositis Cutaneous Manifestation Membrane Attack Complex Anterior Neck Skin Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sontheimer RD, Euwer RL, Costner MI. Dermatomyositis. In: Sontheimer RD, Provost TT, editors. Cutaneous manifestations of rheumatic diseases. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 65–103.Google Scholar
  2. 2.
    Franks AG. Skin manifestations of internal disease. Med Clin North Am. 2009;93:1265.PubMedCrossRefGoogle Scholar
  3. 3.
    Krathen MS, Fiorentino D, Werth VP. Dermatomyositis. Curr Dir Autoimmun. 2008;10:313.PubMedCrossRefGoogle Scholar
  4. 4.
    Callen JP. Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep. 2010;12:192.PubMedCrossRefGoogle Scholar
  5. 5.
    Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54:597.PubMedCrossRefGoogle Scholar
  6. 6.
    Vaughan Jones SA, Black MM. The value of direct immunofluorescence as a diagnostic aid in dermatomyositis: a study of 35 cases. Clin Exp Dermatol. 1997;22:77–81.CrossRefGoogle Scholar
  7. 7.
    Miller FW. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann Rheum Dis. 2012;71(Suppl II):i82–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Weedon D. Dermatomyositis. In: Weedon’s skin pathology. Churchill Livingstone Elsevier; 2010. p. 64–66.Google Scholar
  9. 9.
    Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol. 1997;24:543–52.PubMedCrossRefGoogle Scholar
  10. 10.
    Greenberg SA. Dermatomyositis and type 1 interferons. Curr Rheumatol Rep. 2010;12:198.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of Rheumatology and Immunology, Clinical CenterUniversity of PécsPécsHungary
  2. 2.Department of Pathology, Clinical CenterUniversity of PécsPécsHungary

Personalised recommendations